An Observational Study to Evaluate the Maternal and Foetal Outcomes in Pregnancies Complicated with Jaundice
- 14 Downloads
Abstract
Background
Incidence of jaundice in pregnancy, including underlying chronic liver diseases, is 3–5%. However, the maternal mortality rate in some conditions can be as high as 18% in acute fatty liver of pregnancy and 22% in hepatitis E in pregnancy.
Objectives
This is an observational study of the demographics, obstetrical profile, aetiology, maternal morbidity, mortality and neonatal outcomes in pregnancies complicated with jaundice.
Materials and Methods
This is an observational study conducted in Department of Obstetrics and Gynaecology of a tertiary care hospital, situated amidst the biggest urban slum in Mumbai spanning over 1 year from January 2016 to December 2016. All registered, unregistered and transferred patients with abnormal liver function tests excluding patients with chronic liver diseases were included in this study.
Results
Most of the cases of jaundice in pregnancy were seen in primigravida (51%) and age group of 20–30 years (58%). Fifty-three percentage of cases were referred or transferred from periphery hospitals. Hepatitis E was the most common cause (42%) of jaundice in pregnancy. Complications like disseminated intravenous coagulopathy, postpartum haemorrhage, hepatic encephalopathy and hepatoportal hypertension were seen in 65% of cases. Maternal mortality rate and perinatal mortality rate were as high as 40 and 37%, respectively, in our study.
Conclusion
Incidence of jaundice in pregnancy, mainly due to viral hepatitis, is very high in lower socio-economic, densely populated urban slums. Special efforts should be made to counsel and educate the mothers about initial symptoms and preventive measures for viral hepatitis. Patients along with the relatives should be informed about the severe features of pre-eclampsia to combat these preventable causes of maternal mortality.
Keywords
Jaundice Hepatitis E Maternal mortality PreventableNotes
Compliance with Ethical Standards
Conflict of interest
None.
Ethical Standards
All procedures performed were with the standard of institutional research ethical committee and the 1964 Helsinki declaration and its later amendments.
References
- 1.www.cdc.gov/nchs/icd/icd10cm.htm. Assessed 28 Sept 2017.
- 2.Celik H, Tosun M, Cetinkaya MB, et al. Markedly elevated serum alkaline phosphatase level in an uncomplicated pregnancy. J Matern Fetal Neonatal Med. 2009;22(8):705–7. https://doi.org/10.1080/14767050802702323.CrossRefPubMedGoogle Scholar
- 3.Hay JE. Liver disease in pregnancy. Hepatology. 2008;47(3):1067–76. https://doi.org/10.1002/hep.22130.CrossRefPubMedGoogle Scholar
- 4.Nandi B, Hadimani P, Arunachalam R, et al. Spectrum of acute viral hepatitis in Southern India. Med J Armed Forces India. 2009;65(1):7–9. https://doi.org/10.1016/S0377-1237(09)80044-0.CrossRefPubMedPubMedCentralGoogle Scholar
- 5.Fares A. Seasonality of hepatitis: a review update. J Fam Med Prim Care. 2015;4(1):96–100. https://doi.org/10.4103/2249-4863.152263.CrossRefGoogle Scholar
- 6.Chaudhry SA, Verma N, Koren G. Hepatitis E infection during pregnancy. Can Fam Physician. 2015;61(7):607–8.PubMedPubMedCentralGoogle Scholar
- 7.Zhang Y-P, Kong W-Q, Zhou S-P, et al. Acute fatty liver of pregnancy: a retrospective analysis of 56 cases. Chin Med J. 2016;129(10):1208–14. https://doi.org/10.4103/0366-6999.181963.CrossRefPubMedPubMedCentralGoogle Scholar
- 8.Jeyabalan A. Epidemiology of preeclampsia: impact of obesity. Nutr Rev. 2013. https://doi.org/10.1111/nure.12055.PubMedPubMedCentralGoogle Scholar
- 9.Ellington SR, Flowers L, Legardy-Williams JK, et al. Recent trends in hepatic diseases during pregnancy in the United States, 2002–2010. Am J Obstet Gynecol. 2015;212(4):524.e1-7. https://doi.org/10.1016/j.ajog.2014.10.1093.CrossRefPubMedGoogle Scholar
- 10.Krishnamoorthy J, Murugesan A. Jaundice during pregnancy-maternal and fetal outcome. Int J Reprod Contracept Obstet Gynecol. 2016;5:2541–5.CrossRefGoogle Scholar
- 11.Aparajita D. Maternal and fetal outcome in liver diseases of pregnancy—a tertiary hospital experience. Int J Sci Res Publ. 2015;5(9):1–4.Google Scholar
- 12.English FA, Kenny LC, McCarthy FP. Risk factors and effective management of preeclampsia. Integr Blood Press Control. 2015;8:7–12. https://doi.org/10.2147/IBPC.S50641.PubMedPubMedCentralGoogle Scholar
- 13.Westbrook RH, Dusheiko G, Williamson C. Pregnancy and liver disease. J Hepatol. 2016;64(4):933–45. https://doi.org/10.1016/j.jhep.2015.11.030.CrossRefPubMedGoogle Scholar
- 14.Devarbhavi H, Kremers WK, Dierkhising R, et al. Pregnancy associated acute liver disease and acute viral hepatitis: differentiation, course and outcome. J Hepatol. 2008;49:930–5.CrossRefPubMedGoogle Scholar
- 15.Devi SG, Kumar A, Kar P, et al. Association of pregnancy outcome with cytokine gene polymorphisms in HEV infection during pregnancy. J Med Virol. 2014;86(8):1366–76.CrossRefPubMedGoogle Scholar
- 16.Society for Maternal-Fetal Medicine (SMFM), Dionne-Odom J, Tita AT, Silverman NS. #38: hepatitis B in pregnancy screening, treatment, and prevention of vertical transmission. Am J Obstet Gynecol. 2016;214:6.CrossRefGoogle Scholar
- 17.Ghany MG, Strader DB, Thomas DL, et al. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology. 2009;49:1335–74.CrossRefPubMedGoogle Scholar
- 18.American College of Obstetricians and Gynecologists. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ task force on hypertension in pregnancy. Obstet Gynecol. 2013;122:1122.CrossRefGoogle Scholar
- 19.Eskelin PM, Laitinen KA, Tyni TA. Elevated hydroxyacylcarnitines in a carrier of LCHAD deficiency during acute liver disease of pregnancy—a common feature of the pregnancy complication? Mol Genet Metab. 2010;100(2):204–6.CrossRefPubMedGoogle Scholar
- 20.Kremer AE, Oude Elferink RP, Beuers U. Pathophysiology and current management of pruritus in liver disease. Clin Res Hepatol Gastroenterol. 2011;35:89.CrossRefPubMedGoogle Scholar